ArticleJournal of the National Cancer Center2026

MCLAM: a cost-effective deep learning model for predicting recurrence risk in HR+/HER2- breast cancer-a multi-center study in a Chinese cohort.

Liuliu Quan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.